Bank of America’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History
Bought
Maintained
Sold
Other funds holding KRSA
KA
Bank of America's KRSA Position: Q1 2026 in Review
Bank of America sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q1 2026, closing a stake of 15 shares — an estimated $136 sold.
Bank of America first reported a position in KRSA in Q2 2019 and held it in 19 quarters. The position peaked at $372K in Q2 2019. 16 funds tracked by Wall St. Rank hold KRSA as of Q1 2026.
- Bank of America reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 15 Korsana Biosciences, Inc. Common Stock shares in Q1 2026, an estimated $136.
- Bank of America first reported a position in Korsana Biosciences, Inc. Common Stock in Q2 2019 and held it in 19 quarters.
- Bank of America's Korsana Biosciences, Inc. Common Stock position peaked at $372K in Q2 2019.
- 16 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.